Research into treatments and cures for hemophilia takes place in laboratories all over the country. So it’s no wonder that funding for it comes from a variety of sectors, as explored in a feature article HemAware ran in summer 2013, written by freelance writer Heather Boerner. Bleeding disorders groups, families, foundations and even pharmaceutical companies have all rallied to support research. In this feature, we shared the stories of four groups supporting research critical to improving the lives of people with hemophilia. In fall 2013, we continued our focus on the state of bleeding disorders research by running a feature article written by senior editor Sarah Aldridge about gene therapy clinical trials for hemophilia A, or factor VIII (FVIII) deficiency. Our article explores the current state of clinical trials and what they’re likely to investigate down the road.
